Reversibility of neurofilamentous inclusion formation following repeated sublethal intracisternal inoculums of AlCl3 in New Zealand white rabbits.
In this report, we describe the clinical, topographical and immunohistochemical characteristics of neurofilament (NF) inclusion formation induced by the intracisternal inoculation of young adult New Zealand white rabbits at 28-day intervals with 100 micrograms AlCl3 over the course of 267 days. The ability to recover following cessation of aluminum exposure has also been assessed. The extent of neurofilamentous inclusion formation was proportionate to the cumulative amount of AlCl3 inoculated and initially consisted of fusiform axonal distention in the ventral spinal cord at day 51 following the initial inoculum. Spinal motor neuron perikaryal inclusions and discrete axonal spheroids were observed at day 107 and supraspinal neurofilamentous pathology by day 156. Perikaryal inclusions were immunoreactive to antibodies recognizing both poorly phosphorylated (SMI 32) and more highly phosphorylated high molecular weight NF (NFH). In contrast, axonal spheroids were intensely immunoreactive at all stages with antibodies recognizing highly phosphorylated NFH and an age-dependent NFH phosphorylation state (SMI 34) with only faint SMI 32 immunoreactivity. Immunoreactivity to an antibody recognizing ubiquitin-protein conjugates did not appear until day 156, whereas inclusions were not immunoreactive to antibodies recognizing either phosphatase-dependent or -independent microtubule-associated protein tau at any stage. Upon withdrawal from further AlCl3 exposure after intervals of 51, 107 or 156 days following the initial inoculum, clinical recovery ensued in all rabbits. In all but the most severely affected rabbits, perikaryal neurofilamentous inclusions resolved. However, axonal spheroids continued to be prominent. These studies demonstrate that the repetitive intracisternal inoculation of AlCl3 in New Zealand white rabbits induces a reversible process of neurofilamentous inclusion formation that preferentially affects motor neurons, and in which recovery will occur in those inclusions containing an admixture of both poorly and highly phosphorylated NFH.
Strong
M J
MJ
John P. Robart's Research Institute, University of Western Ontario, London, Canada.
Gaytan-Garcia
S
S
Jakowec
D M
DM
D000077410:Aluminum Chloride; D017607:Aluminum Compounds / Q000494:pharmacology* / Q000633:toxicity*; D000818:Animals; D002712:Chlorides / Q000494:pharmacology* / Q000633:toxicity*; D005260:Female; D007150:Immunohistochemistry; D007278:Injections, Spinal; D009046:Motor Neurons / Q000187:drug effects*; D016900:Neurofilament Proteins / Q000187:drug effects / Q000648:ultrastructure*; D011817:Rabbits; D013116:Spinal Cord / Q000187:drug effects; D013997:Time Factors
D017607:Aluminum Compounds; D002712:Chlorides; D016900:Neurofilament Proteins; D000077410:Aluminum Chloride